Literature DB >> 22108642

Diffusion tensor imaging characterization of occult brain damage in relapsing neuromyelitis optica using 3.0T magnetic resonance imaging techniques.

Dai-Di Zhao1, Hong-Yu Zhou, Qi-Zhu Wu, Ju Liu, Xiu-Ying Chen, Dian He, Xiao-Fei He, Wen-Jie Han, Qi-Yong Gong.   

Abstract

Studies of relapsing neuromyelitis optica (RNMO) using advanced MRI techniques are limited compared with those done on multiple sclerosis (MS). The present study used diffusion tensor imaging (DTI) to investigate whether occult brain damage exists in RNMO patients. DTI scans using a 3.0T MRI scanner were performed in 24 clinically confirmed RNMO patients whose conventional brain MRI results were normal, and also in 24 age- and sex-matched healthy control subjects. DTI data were processed to generate fractional anisotropy (FA) and mean diffusivity (MD) maps, and region of interest (ROI) analyses were performed to obtain these parameters in white matter (including medulla oblongata, cerebral peduncle, optic radiation, genu of corpus callosum, splenium of corpus callosum, and internal capsule) and gray matter (including thalamus and putamen). Regional measures from patients at stable and acute phases were compared with healthy controls. Both acute and stable NMO patients had a higher average FA in ROIs of the thalamus and putamen. Acute NMO patients had significantly higher average MDs than controls in the genu of corpus callosum and optic radiation, and significantly lower average MDs in the medulla oblongata. Stable NMO patients had increased MDs in the genu of corpus callosum and optic radiation, but lower MDs in the medulla oblongata, internal capsule and thalamus. The DTI findings confirm the presence of occult tissue damage in normal-appearance white and gray matter, especially deep gray matter, in RNMO patients. This study adds further to the evidence that DTI is suitable as a tool for characterizing subtle brain tissue damage.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22108642     DOI: 10.1016/j.neuroimage.2011.11.022

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  21 in total

Review 1.  Tracking cerebral white matter changes across the lifespan: insights from diffusion tensor imaging studies.

Authors:  Qian Jun Yap; Irvin Teh; Paolo Fusar-Poli; Min Yi Sum; Carissa Kuswanto; Kang Sim
Journal:  J Neural Transm (Vienna)       Date:  2013-01-18       Impact factor: 3.575

2.  Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Authors:  F Pache; H Zimmermann; C Finke; A Lacheta; S Papazoglou; J Kuchling; J Wuerfel; B Hamm; K Ruprecht; F Paul; A U Brandt; M Scheel
Journal:  Eur Radiol       Date:  2016-03-24       Impact factor: 5.315

3.  Variation in anisotropy and diffusivity along the medulla oblongata and the whole spinal cord in adolescent idiopathic scoliosis: a pilot study using diffusion tensor imaging.

Authors:  Y Kong; L Shi; S C N Hui; D Wang; M Deng; W C W Chu; J C Y Cheng
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-30       Impact factor: 3.825

4.  Lower Prefrontal and Hippocampal Volume and Diffusion Tensor Imaging Differences Reflect Structural and Functional Abnormalities in Abstinent Individuals with Alcohol Use Disorder.

Authors:  Ashwini Kumar Pandey; Babak Assai Ardekani; Chella Kamarajan; Jian Zhang; David Balin Chorlian; Kelly Nicole-Helen Byrne; Gayathri Pandey; Jacquelyn Leigh Meyers; Sivan Kinreich; Arthur Stimus; Bernice Porjesz
Journal:  Alcohol Clin Exp Res       Date:  2018-08-17       Impact factor: 3.455

Review 5.  Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder.

Authors:  Stephane Kremer; Felix Renard; Sophie Achard; Marco A Lana-Peixoto; Jacqueline Palace; Nasrin Asgari; Eric C Klawiter; Silvia N Tenembaum; Brenda Banwell; Benjamin M Greenberg; Jeffrey L Bennett; Michael Levy; Pablo Villoslada; Albert Saiz; Kazuo Fujihara; Koon Ho Chan; Sven Schippling; Friedemann Paul; Ho Jin Kim; Jerome de Seze; Jens T Wuerfel; Philippe Cabre; Romain Marignier; Thomas Tedder; Danielle van Pelt; Simon Broadley; Tanuja Chitnis; Dean Wingerchuk; Lekha Pandit; Maria Isabel Leite; Metha Apiwattanakul; Ingo Kleiter; Naraporn Prayoonwiwat; May Han; Kerstin Hellwig; Katja van Herle; Gareth John; D Craig Hooper; Ichiro Nakashima; Douglas Sato; Michael R Yeaman; Emmanuelle Waubant; Scott Zamvil; Olaf Stüve; Orhan Aktas; Terry J Smith; Anu Jacob; Kevin O'Connor
Journal:  JAMA Neurol       Date:  2015-07       Impact factor: 18.302

6.  Gray Matter Volume Reduction Is Associated with Cognitive Impairment in Neuromyelitis Optica.

Authors:  Q Wang; N Zhang; W Qin; Y Li; Y Fu; T Li; J Shao; L Yang; F-D Shi; C Yu
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-03       Impact factor: 3.825

Review 7.  Conventional and advanced imaging in neuromyelitis optica.

Authors:  Y Barnett; I J Sutton; M Ghadiri; L Masters; R Zivadinov; M H Barnett
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-13       Impact factor: 3.825

Review 8.  Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.

Authors:  Joseph Kuchling; Alexander U Brandt; Friedemann Paul; Michael Scheel
Journal:  EPMA J       Date:  2017-07-25       Impact factor: 6.543

Review 9.  Neuromyelitis optica: clinical features, immunopathogenesis and treatment.

Authors:  S Jarius; B Wildemann; F Paul
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

10.  Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.

Authors:  Carlos A Sánchez-Catasús; José Cabrera-Gomez; William Almaguer Melián; José Luis Giroud Benítez; Rafael Rodríguez Rojas; Jorge Bosch Bayard; Lídice Galán; Reinaldo Galvizu Sánchez; Nancy Pavón Fuentes; Pedro Valdes-Sosa
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.